Over the past decade, scientists working at the National Institutes of Health (NIH) have earned an estimated $400 million in royalties from third-party companies for medical treatments and innovations they've helped produce. The NIH often provides grants to these same companies and produces research on their products. Despite that, the agency has resisted disclosing how much its scientists are getting paid and by whom.
A bill moving its way through Congress would change that.
